Drug Profile
OMTX 705
Alternative Names: Anti-FAPα:Cytolysin ADC; OMTX-705Latest Information Update: 05 Jun 2023
Price :
$50
*
At a glance
- Originator Oncomatryx
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Mitosis inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Solid tumours